Anzeige
Mehr »
Mittwoch, 13.05.2026 - Börsentäglich über 12.000 News
Bahnbrechende KI-Lösung "Ohne Nadelstiche" als Ersatz für herkömmliche Bluttests "unlocked"?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1JLYP | ISIN: KYG211081248 | Ticker-Symbol: 2M7C
Tradegate
13.05.26 | 18:40
1,300 Euro
-0,76 % -0,010
Branche
Gesundheitswesen
Aktienmarkt
ASIEN
1-Jahres-Chart
CHINA MEDICAL SYSTEM HOLDINGS LTD Chart 1 Jahr
5-Tage-Chart
CHINA MEDICAL SYSTEM HOLDINGS LTD 5-Tage-Chart
RealtimeGeldBriefZeit
1,2301,31020:49
1,2601,31020:50

Aktuelle News zur CHINA MEDICAL SYSTEM Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
27.04.Dividendenbekanntmachungen (27.04.2026)12.594 Unternehmen  ISIN-Code  Dividende (Währung)  Dividende (EUR)  ABN AMRO BANK NV ADR  US00080Q1058  0,356 USD  0,3038 EUR  AEON THANA SINSAP THAILAND PCL NVDR  TH0664010R11  2,95 THB  0,0778 EUR  AKZO...
► Artikel lesen
CHINA MEDICAL SYSTEM Aktie jetzt für 0€ handeln
27.04.China Medical System Holdings Limited: CMS (867.HK/8A8.SG) Signed An Exclusive Commercialization and Supply Agreement for Marketed Originator Intravenous Iron Products Monofer(R) and Cosmofer(R)336SHENZHEN, Apr 27, 2026 - (ACN Newswire) - China Medical System Holdings Limited ("CMS" or the "Group") is pleased to announce that, the Group through its wholly-owned subsidiary entered into an exclusive...
► Artikel lesen
27.04.China Medical System Holdings Ltd.: CMS (867.HK/8A8.SG) Signed An Exclusive Commercialization and Supply Agreement for Marketed Originator Intravenous Iron Products Monofer and Cosmofer516SHENZHEN, CHINA, April 27, 2026 (GLOBE NEWSWIRE) -- China Medical System Holdings Limited ("CMS" or the "Group") is pleased to announce that, the Group through its wholly-owned subsidiary entered...
► Artikel lesen
23.04.China Medical System Holdings Limited: CMS (867.HK; 8A8.SG): NDA for the Seasonal Allergic Rhinitis Indication of Class 1 Innovative Drug MG-K10 Accepted in China461SHENZHEN, Apr 23, 2026 - (ACN Newswire) - China Medical System Holdings Limited (the "Group" or "CMS") is pleased to announce that the New Drug Application (NDA) in China for the Seasonal Allergic Rhinitis...
► Artikel lesen
23.04.CMS (00867): ANNOUNCEMENT ON VOTING RESULTS OF ANNUAL GENERAL MEETING HELD ON 23 APRIL 2026-
23.04.CMS (00867): VOLUNTARY AND BUSINESS UPDATE ANNOUNCEMENT NEW DRUG APPLICATION FOR THE SEASONAL ALLERGIC RHINITIS INDICATION OF CLASS 1 INNOVATIVE DRUG ...1
01.04.CMS (00867): FORM OF PROXY-
01.04.CMS (00867): NOTICE OF ANNUAL GENERAL MEETING-
01.04.CMS (00867): PROPOSALS FOR (1) RE-ELECTION OF THE RETIRING DIRECTORS (2) DECLARATION OF FINAL DIVIDEND (3) GENERAL MANDATES TO ISSUE SHARES AND TO REPURCHASE ...-
01.04.CMS (00867): ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT 2025-
01.04.CMS (00867): ANNUAL REPORT 2025-
17.03.CMS (00867): TERMS OF REFERENCE OF THE NOMINATION COMMITTEE2
17.03.CMS (00867): LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION1
17.03.CMS (00867): FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 20251
16.03.China Medical System Holdings Limited Full Year Income Falls1
16.03.CMS (00867): ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2025 AND CHANGE OF MEMBER OF THE ENVIRONMENTAL, SOCIAL AND GOVERNANCE COMMITTEE1
13.03.China Medical System Holdings Ltd.: CMS(867.HK/8A8.SG): New Drug for Renal Anaemia Desidustat Tablets Approved in China2
13.03.CMS (00867): VOLUNTARY AND BUSINESS UPDATE ANNOUNCEMENT NEW DRUG FOR RENAL ANAEMIA DESIDUSTAT TABLETS APPROVED IN CHINA1
13.03.China Medical System Holdings Ltd.: CMS(867.HK/8A8.SG):Ruxolitinib Phosphate Cream (Lumirix) Achieves Initial Prescriptions in Multiple Regions in China for Patients with Vitiligo1
05.03.China Medical System Holdings Ltd.: CMS(867.HK/8A8.SG): Self-Developed INHBE-Targeting siRNA Drug Received IND Approval for Overweight/Obesity1
Weiter >>
40 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1